Bluestein R H & CO LLC Illumina, Inc. Transaction History

Bluestein R H & CO LLC

$1.61 Billion
Q3 2022

A detailed history of Bluestein R H & CO LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Bluestein R H & CO LLC holds 1,205 shares of ILMN stock, worth $164,687. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,205

Previous 1,205 -0.0%

Holding current value

$164,687

Previous $222,000 3.6%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $1.42 Million - $1.72 Million	-4,086 Reduced 77.23%	1,205 $458,000
Q3 2021 Nov 12, 2021	SELL	$405.61 - $524.84 $10.1 Million - $13.1 Million	-24,934 Reduced 82.49%	5,291 $2.15 Million
Q2 2021 Aug 13, 2021	SELL	$372.84 - $481.5 $3.37 Million - $4.36 Million	-9,045 Reduced 23.03%	30,225 $14.3 Million
Q1 2021 May 12, 2021	BUY	$361.28 - $504.76 $13.8 Million - $19.3 Million	38,270 Added 3827.0%	39,270 $15.1 Million
Q3 2020 Nov 12, 2020	SELL	$268.51 - $400.74 $5,370 - $8,014	-20 Reduced 1.96%	1,000 $309,000
Q2 2020 Aug 12, 2020	BUY	$256.46 - $373.01 $5,129 - $7,460	20 Added 2.0%	1,020 $378,000
Q3 2019 Nov 13, 2019	SELL	$266.84 - $378.23 $226,813 - $321,495	-850 Reduced 45.95%	1,000 $304,000
Q2 2019 Aug 12, 2019	BUY	$300.59 - $368.15 $75,147 - $92,037	250 Added 15.63%	1,850 $681,000
Q1 2019 May 10, 2019	SELL	$272.57 - $321.18 $136,285 - $160,590	-500 Reduced 23.81%	1,600 $497,000
Q4 2018 Feb 13, 2019	BUY	$272.46 - $366.54 $81,738 - $109,962	300 Added 16.67%	2,100 $630,000
Q1 2018 May 10, 2018	SELL	$209.54 - $253.91 $41,908 - $50,782	-200 Reduced 10.0%	1,800 $426,000
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $344,600 - $427,860	2,000	2,000 $398,000

Others Institutions Holding ILMN

# of Institutions

904

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.

Account

Bluestein R H & CO LLC Illumina, Inc. Transaction History